author-photo

Yaoshi Wu

Genzyme

6

Papers

17

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Long-term adverse event profile from four completed trials of oral eliglustat in adults with Gaucher disease type 1

2018 Molecular Genetics and Metabolism
Show All
- Source
- Cite
- Save
Citations (3)
Long-term treatment response based on severity of Gaucher disease type 1 at baseline after 8 years of treatment with oral eliglustat: Final efficacy and safety results from a phase 2 clinical trial in treatment-naïve adult patients

2018 Molecular Genetics and Metabolism
Show All
- Source
- Cite
- Save
Citations (0)
Once- versus twice-daily dosing of eliglustat in adults with Gaucher disease type 1: The Phase 3, randomized, double-blind EDGE trial

2018 Molecular Genetics and Metabolism
Show All
- Source
- Cite
- Save
Citations (11)
Long-term results of ENGAGE: a phase 3, randomized, double‑blind, placebo-controlled, multi‑center study investigating the efficacy and safety of eliglustat in adults with type 1 Gaucher disease

2017 Molecular Genetics and Metabolism
Show All
- Source
- Cite
- Save
Citations (3)